ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 617

$449K Total Retail Price of All Prescriptions

Rank: 126 out of 617

393 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,227 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 368 329 1 1
OMEPRAZOLE 275 235 2 3
HYDROCODONE-ACETAMINOPHEN 242 182 S3 3 8
SIMVASTATIN 202 185 4 2
AMLODIPINE BESYLATE 201 185 5 6
TRAMADOL HCL 192 170 6 15
HYDROCHLOROTHIAZIDE 191 159 7 13
METOPROLOL SUCCINATE 186 160 8 12
LISINOPRIL 178 172 9 5
MELOXICAM 161 158 10 24
ZOLPIDEM TARTRATE 158 141 11 23
GABAPENTIN 150 135 12 16
FUROSEMIDE 146 145 13 4
ATENOLOL 135 115 14 17
WARFARIN SODIUM 133 93 15 7
METFORMIN HCL 131 112 16 9
CITALOPRAM HBR 121 93 17 18
METOPROLOL TARTRATE 112 102 18 11
DONEPEZIL HCL 104 104 19 30
POTASSIUM CHLORIDE 101 89 20 10
NEXIUM 100 96 21 43
NAMENDA 93 88 22 35
ALENDRONATE SODIUM 89 76 23 25
TRIAMTERENE-HCTZ 85 78 24 47
PANTOPRAZOLE SODIUM 82 78 25 37
PREDNISONE 81 72 26 31
ATORVASTATIN CALCIUM 79 62 27 14
FLUTICASONE PROPIONATE 66 52 28 36
LIDODERM 63 59 29 188
RANITIDINE HCL 63 54 29 40
CARVEDILOL 61 61 31 19
GLIPIZIDE ER 59 59 32 94
CELEBREX 58 52 33 63
ISOSORBIDE MONONITRATE ER 57 52 34 52
SERTRALINE HCL 57 44 34 20
ESCITALOPRAM OXALATE 57 41 34 65
MIRTAZAPINE 56 51 37 50
PREMARIN 55 46 R 38 108
ALLOPURINOL 54 47 39 27
AMITRIPTYLINE HCL 52 49 R 40 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 41 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.